Valley Village, California Clinical Trials

A listing of Valley Village, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 73 clinical trials
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

sarcoma
lung non-small cell squamous carcinoma
cisplatin/gemcitabine
small cell lung cancer
pemetrexed
Providence Saint Joseph Medical Center/Disney Family Cancer Center
 (2.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +358 other locations
NA-831 Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.

covid-19
combination therapy
acute respiratory syndrome (sars)
complete blood count
cervical cap
Coronavirus Research Institute- Testing Site
 (7.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +29 other locations
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

factor ix
severe haemophilia a
antihemophilic factor
hemophilia
fitusiran
Investigational Site Number 8400002
 (7.5 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +10 other locations
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants  

Primary Objective: To assess the safety profile of each SP0202 formulation and Prevnar 13 in toddlers and infants (after each and any injection). To assess the immune response (serotype specific IgG concentration) of the SP0202 formulations and Prevnar 13 1 month after the administration of one dose in toddlers (Groups …

Investigational Site Number 8400059
 (9.2 away)
  • 0 views
  • 17 Nov, 2020
  • +30 other locations
An Open-label Ascending Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)

Primary Objective: To describe the pharmacokinetic (PK) profile of sarilumab in patients aged 2-17 years with Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) in order to identify the dose and regimen for adequate treatment of this population Secondary Objective: To describe the pharmacodynamic (PD) profile, the efficacy and the long-term safety of …

arthritis
disease modifying antirheumatic drugs
sarilumab
rheumatoid factor
antirheumatic
Investigational Site Number 8400416
 (5.9 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +32 other locations
A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)

In this study, participants with multiple types of advanced (unresectable and/or metastatic) solid tumors who have progressed on standard of care therapy will be treated with pembrolizumab (MK-3475).

Call for Information (Investigational Site 0017)
 (6.2 away) Contact site
  • 0 views
  • 20 Jul, 2022
  • +23 other locations
A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186

This study will assess the safety, tolerability, and pharmacokinetics of AZD0186 following single ascending doses (SAD) via oral administration in healthy adult participants.

Accepts healthy volunteers
Research Site
 (9.8 away) Contact site
  • 0 views
  • 01 Feb, 2023
  • 1 location
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

medical therapy
tricuspid valve replacement
Cedars-Sinai Medical Center
 (6.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Skin Care & Laser Physicians of Beverly Hills
 (4.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …

definitive treatment
chemoradiotherapy
neutrophil count
oral contraceptives
treatment regimen
Providence Saint Joseph Medical Center/Disney Family Cancer Center
 (2.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +254 other locations